ABSTRACT
The expression of most eukaryotic genes is regulated by transcriptional activator proteins that bind to sites in the promoter called upstream activation sequences (UASs) . In addition to a sequence-specific DNA-binding domain (DBD), these proteins also contain an activation domain (AD), which is essential for transcriptional stimulation but is not required for DNA binding in vitro. The function of these domains is unknown and is a matter of intense current interest. Many ADs have been shown to bind general transcription factors (TFs), including the TATA-binding protein (TBP) (1) (2) (3) (4) (5) (6) (7) , which binds the TATA box DNA sequence present in many promoters. Some ADs bind TFIIB in vitro, an adaptor protein required for binding of the polymerase to the general transcription complex (8) (9) (10) . Finally, some ADs associate with TBP-associated factors (11, 12) , the proteins that together with TBP comprise TFIID (13) . It is generally thought that these contacts play a central role in the activation process. One possibility is that these interactions stabilize the transcription complex at the promoter through cooperative binding of the activator and general transcription factor(s) to their respective sites in the promoter. Another is that a stably bound activator recruits its target protein to the promoter and thus kinetically stimulates some otherwise rate-determining step in assembly of the transcription complex. Some in vitro data are in accord with one or both of these models, but many conflicting results have been reported. It is extremely important to evaluate the biological relevance of in vitro probes of the mechanism of action of ADs, such as studies of AD-TF interactions, mechanistic experiments using artificial chimeric activators, etc. For example, there are several documented cases of strong and apparently specific protein-protein interactions in vitro that have no biological relevance. One of the best known cases is the actin-DNase I complex (14) . These proteins act in unrelated metabolic pathways, yet actin binds tightly in DNase I in vitro and inhibits its nuclease activity. Even more alarming, given the topic at hand, is the recent finding of Melcher and Johnston that the AD of the yeast GAL4 activator protein binds tightly to bacterial lysozyme in vitro, an interaction that clearly does not occur naturally. Indeed, the affinity for lysozyme exhibited by various mutant GAL4 ADs and ADs from other proteins was found to correlate with the ability of GAL4 derivatives containing these domains to activate transcription in vivo (K. Melcher and S. Johnston, personal communication). This highlights the need to go beyond simple correlations. It would be far preferable to design precise in vivo experiments that probe particular mechanistic models for activator function inside the cell under conditions that are as close to physiological as possible.
Using the GAL4 system in yeast (15) , we have pursued exactly such an approach and report here an in vivo test of the idea that activators and proteins that bind at or near the TATA region occupy promoters cooperatively. A simple prediction of a cooperative binding model is that the presence of a nearby TATA box should stimulate association of GAL4 with sites for which it has a modest intrinsic affinity. This question could be addressed easily if we could quantitate in vivo the relative affinity of GAL4 for UASs that are or are not near a TATA sequence. Using the recently developed "plasmid titration" method (16) to monitor GAL4-DNA interactions in vivo, we show that the binding of GAL4 to low-or moderate-affinity UASs is indeed strongly affected by the presence of a TATA box. We also demonstrate that substitution of the native GAL4 AD with that of VP16 results in altered DNA-binding properties, consistent with the idea that the AD mediates the contacts that support cooperative promoter binding. Interestingly, these data also show that the activities of DBD and AD in GAL4, and presumably other activators, are not cleanly separable as is currently thought to be the case (17) . Rather, the AD plays an important role in occupancy of some promoters.
MATERIALS AND METHODS
Plasmid Titration Assays. Plasmid titration assays were used to measure the affinity of GAL4 for various sequences in vivo in the presence and absence of a nearby TATA box. The GAL4-binding sites used were the cUAS, an artificial concensus 17-bp sife (16) (5'-CGGAGGACTGTCCTCCG-3'); the natural GAL4-binding site in the MELl promoter (5'-CGG-CCATATGTCTTCCG-3'); UAS3, the third of four GAL4-binding sites in the GALl-GAL10 UAS (5'-AGGAAGACT-CTCCTCCG-3'); and the entire GALl-GAL10 UAS, containing four adjacent GAL4-binding sites. YEp352 (18) Yeast strain YJOZG4 [(GAL4:1eu2)::1eu2-3,112 gal4 gal8O ura3-52 his3 trpl ade2-101 GALl-10-lacZ] wvas transformed with the appropriate titration plasmid to midlogarithmic phase in minimal medium lacking either uracil (when YEp352 derivatives were used) or leucine (when YEp351 derivatives were used). The carbon source was 3% glycerol and 2% lactic acid. a-Galactosidase (the product of the MEL1 gene) assays using whole cell extracts were performed as described (20) . The results shown in Fig. 1 were derived from at least three independent measurements and have an error of ±5%.
The copy number of the titration plasmids was determined by quantitative Southern blotting. The plasmid DNAs containing the various GAL4-binding sites were isolated from yeast as described (21) . The DNAs were then quantitated by their ability to hybridize to a 3'-radiolabeled (22) 1200-bp URA3 probe, which was derived by cutting YEp352 with BamHI and Nde I.
Reporter Plasmid Experiments. The binding sites tested were cloned into pJLb, a plasmid containing the ,-galactosidase reporter gene, as described (19), except for the MEL] promoter. In this case, a PCR-amplified fragment spanning the native promoter from just upstream of the UAS to just downstream of the transcriptional start site was inserted into BamHI/Sal I-cut pJLb. The reporter plasmid was transformed into yeast strain YJO, lacking the chromosomal GAL4 gene, containing a centromere-containing plasmid expressing either GAL4 or GAL4-(1-841)-viral protein (VP) 16 from the native GAL4 promoter [pSB32-GAL4 (23) and pSB32-GAL4-(1-841)-VP16 (24)]. Transformed cells were grown on minimal medium lacking uracil and leucine to midlogarithmic phase and then harvested. The carbon source was 2% galactose, 3% glycerol, and 2% lactic acid. When desired, overexpression of GAL4 or GAL4-(1-841)-VP16 was achieved by transforming YJO with the high copy number plasmids YEp351-GAL4 (23) and YEp351-GAL4-(1-841)-VP16 (16), respectively. 13-Galactosidase assays with whole cell extracts were performed as described (19, 20) . P-Galactosidase activity is reported in Miller units. The values are accurate to within ±10% and are the result of at least three independent measurements.
RESULTS
The Presence of a Nearby TATA Box Increases the Affinity of GAL4 for Low-Affinity, but Not High-Affinity, UASs in Vivo. GAL4 protein binds as a dimer (25) , has a modest effect on binding to the high-affinity cUAS site, and has no effect on the activator-saturated GALI-GALIO UAS. The latter contains four adjacent 17-mers to which GAL4 binds cooperatively. The data have an error margin of ±5% and are the result of at least three independent measurements. modest drop in a-galactosidase activity resulted (7% inhibition). Our experimental error was sufficiently small (+5%) to distinguish this from the result using the control plasmid with no specific GAL4-binding sites. However, when the titration plasmid contained the CYCI TATA region in addition to the MELI UAS, a much more robust inhibition of reporter gene transcription was observed, indicating an -3.5-fold increase in the affinity of the GAL4 activator for the plasmid-borne site. The same 24% inhibition of a-galactosidase expression was observed when the titration plasmid carried the entire native MEL] promoter (data not shown), arguing that no other sequences other than the UAS and the TATA region influence cooperative binding. Quantitative Southern blotting showed that the presence of the other promoter sequences did not affect the plasmid copy number.
When the competitor plasmid contained a TATA box, but no GAL4-binding site, a-galactosidase expression was unaffected (Fig. 2) . This demonstrates that the observed effect of the TATA box in the above experiment is GAL4 specific and is not due to titration of some general TF. Indeed, the latter scenario is almost impossible since there are thousands of TATA boxes in the cell. The addition of a dozen or so extra sites represents a very small change (<1%) and could not account for the much larger effects seen here.
The MEL] UAS is a moderate-affinity GAL4-binding site (19) . We also examined the effect of coupling a TATA box with a very weak GAL4-binding site, UAS3, the third of four 17-mers found in the UAS between the GALl and GAL1O genes. In this case, the TATA box effect was even more striking (Fig. 2) . Although we used a titration plasmid that has about a 2-fold higher copy number (25 per cell) than that used in the MEL] UAS experiment, no effect of the UAS3 site on endogenous MEL] expression was detected, reflecting the very low affinity of this site for the activator. However, when coupled with a TATA box, 25 copies of the UAS3 site inhibited MEL] expression to a significant degree (9%). This must represent a very large increase in affinity for GAL4, although it is impossible to say exactly how large, since the UAS alone is unable to compete with chromosomal sites for GAL4.
In the above experiments, the presence of the TATA box transformed a very-low-affinity UAS (UAS3) into a moderateaffinity site and a moderate-affinity UAS (MEL1) into a high-affinity site. If these results truly reflect cooperative binding between GAL4 and TATA-bound factors, then the presence or absence of a TATA box should have much less effect on high-affinity GAL4-binding sites since the activator is less dependent on cooperativity to fill strong sites. To test this prediction, we used a competitor plasmid that carried the entire GALl-GALIO UAS, which is saturated with GAL4 protein under normal physiological conditions (20) . This UAS contains four 17-mers to which the activator binds tightly and cooperatively (26) . In this case, the same levels of MEL] expression (within experimental error) were observed whether or not a TATA box was also present (Fig. 2) (19) and is -75% saturated with GAL4 under normal physiological conditions (16) . The results of the experiments shown in Fig. 2 are consistent with cooperative binding of GAL4 and factors associated with the TATA box. When the intrinsic affinity of GAL4 for the UAS site is low, cooperativity plays a large role in facilitating promoter-activator interactions, but this effect becomes less important as the intrinsic affinity of GAL4 for its site increases.
A Role for the GAL4 AD in DNA Binding in Vivo. We next asked whether the acidic AD of GAL4 plays a role in cooperative binding, as might be predicted from in vitro results that show interactions between the AD and TBP (7) . To do this, we determined whether substitution of the natural AD of GAL4 protein [comprising 34 residues near the C terminus of the protein (27, 28) (24) .
The results are shown in where GAL4 and GAL4-VP16 were overexpressed as described.
observed using several sites that deviate somewhat from the consensus sequence but retain relatively high affinity for the GAL4 DBD in vitro (19) (entries 2, 4, 6, and 7). However, sites that diverge to a greater degree from the consensus provided very different results. In these cases, wild-type GAL4 activated transcription to a level that was severalfold higher than that .supported by GAL4-(1-841)-VP16 (entries 3, 5, 8, 9, and 10). A particularly striking example was the MEL1 UAS (entry 3). In this case, the level of GAL4-(1-841)-VP16-mediated reporter gene expression was at least 16-fold lower than that observed in the presence of wild-type GAL4. The true ratio is probably even greater (>200), since the 13 units of B3-galactosidase activity observed in the GAL4-(1-841)-VP16-containing cells is very close to the basal level of transcription. A cooperative binding model further predicts that if the activator is overexpressed, then the importance of cooperativity should be diminished since at higher concentrations the GAL4 dimer would fill its site more efficiently even without assistance from another factor. Therefore, we repeated the experiment with the MELI UAS-containing reporter plasmid but expressed the GAL4 and GAL4-(1-841)-VP16 proteins from multicopy plasmids that increased the level of activator 15-to 20-fold. As shown in Table 2 , although wild-type GAL4 protein-mediated activation was still more potent, the difference was <5-fold, as opposed to the much larger ratio (16 to >200) observed when the activators were expressed from single copy plasmids. This type of nonlinear behavior with respect to the protein concentration is a hallmark of cooperative binding phenomena.
DISCUSSION
Several schemes for AD function have been proposed based largely on in vitro observations of direct AD-TF contacts and speculation as to what the biochemical manifestations of these contacts may be. Less frequently, quantitative biochemical experiments have been carried out to test these hypotheses. (30) and Lieberman and Berk (31, 32) have probed this point in vitro by using the p53 and Zta activation proteins, respectively. In the former case, cooperative binding of TBP and p53 to DNA was observed. In the latter experiments, Zta was observed to reduce the dissociation rate of TFIID (the multiprotein complex containing TBP) from promoters containing low-affinity, nonconsensus TATA boxes.
Very few attempts have been made to test models for activation of transcription in vivo in a detailed fashion (33) . This is due in part to the fact that it is much more difficult to carry out quantitative biochemistry in vivo than it is with purified or partially purified proteins in vitro. To begin to tackle this problem, we have devised a method to probe the influence of a TATA box on the affinity of the yeast GAL4 activator for a nearby UAS. We find that the presence of a TATA box significantly increases the affinity of GAL4 protein for nearby low-to moderate-affinity UASs. For example, a TATA box located 200 bp downstream of the MEL] UAS increases its affinity for GAL4 protein by a factor of -3.5. The TATA-coupled MEL] site behaves in the plasmid titration assay as if it were a high-affinity UAS (the fact that the plasmid-borne MEL] promoter is saturated with GAL4 but the chromosomal site is not presumably due to the fact that the former is present at a 12-fold higher concentration in the cell). An even larger effect was observed with a weak GAL4-binding site, UAS3. However, the presence of a TATA box had no effect on the affinity of GAL4 for the activator-saturated GALl-GAL10 UAS and only a modest effect on the highaffinity cUAS. These data are consistent with cooperativity being important for efficient occupancy of moderate-to low-affinity UASs, but not high-affinity sites, at normal physiological levels of GAL4.
We presume that cooperativity is the result of direct activator-TF contacts. Other possible interpretations of the data seem less reasonable, but they cannot be ruled out. For example, one might propose that the presence of a TATA box stimulates binding of GAL4 by some nonspecific effect, such as altering the nucleosome structure of the UAS region. However, UASs recognized by GAL4 are presumed to be constitutively nucleosome-free (34) (35) (36) (37) . In vitro observations of GAL4 AD binding to TBP implicate this contact as the one that mediates cooperative binding in vivo. While our in vivo data are completely consistent with this idea, we stress that they do not provide direct evidence that TBP is the target of the AD. This will require some type of more direct approach. On the activator side, however, the data in Tables 1 and 2 argue that it is the AD that mediates cooperation between GAL4 and its in vivo partner, whether it be TBP or some other protein. This was demonstrated by a domain swap experiment in which the core AD of native GAL4 protein was replaced with that of VP16. We found that the relative ability of wild-type GAL4 and GAL4-(1-841)-VP16 to mediate transcription from a variety of UASs differed substantially, showing that the nature of the AD affects the DNA-binding properties of the activator. This is most easily explained by proposing that the GAL4 and VP16 ADs have different affinities for the target protein (or possibly bind different targets) and thus support different levels of cooperativity. There is no evidence that ADs directly affect the intrinsic affinity of the GAL4 DBD for UASs, although this possibility cannot be excluded. We note that this indirect role for ADs in DNA-binding in vivo shows that in the context of a natural activator protein, the functions of the AD and DBD are not strictly separable.
While our experiments suggest that a major role of acidic ADs is to facilitate promoter occupancy, this does not mean that AD-dependent recruitment of a general factor to the promoter is necessarily the rate-limiting step in transcription or that ADs do not have other important functions. For example, in vivo footprinting experiments have indicated that some TATA boxes are occupied even in the absence of an activator while some are not (38) (39) (40) (41) (42) (43) (44) (45) (46) . This is perhaps not surprising when considered in the context of a cooperative binding model if one accepts that both the UAS and the TATA box must be filled in order to achieve high-level transcription. Depending on the particular promoter sequence, one could imagine a spectrum of possibilities. At one extreme is the situation commonly invoked, in which a high-affinity UAS is saturated with activator while TATA box occupancy must be facilitated because of a nonconsensus core sequence or interference due to nucleosome structure (47) (48) (49) . On the other hand, in promoters with high-affinity core regions and weak UASs, it is probably more appropriate to think of the core promoterbound factor(s) recruiting the activator to the UAS. Yet these genes are not transcribed in the absence of an activator. There is a spectrum of possibilities between these extremes. It seems reasonable to propose that occupation of both the UAS and core regions of the promoter is necessary, but not sufficient, for high-level transcription. Other events, possibly catalyzed by mediators or coactivators (50) (51) (52) (53) , are probably required as well.
Many insights into the biochemistry of gene activation will continue to be gleaned from in vitro systems composed of highly or partially purified TFs, which constitute a powerful tool to probe the mechanism of regulation. As this work progresses it will become increasingly important to devise in vivo probes to evaluate the biological relevance of these findings. While it is quite difficult to test detailed mechanistic models in vivo under normal physiological conditions, only through this type of two-track approach will we eventually reach a satisfying understanding of the mechanism of transcriptional regulation in eukaryotic cells.
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